Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

New anti-HIV agents in early development at Janssen

Oct. 15, 2004

Novel inhibitors of EGFR-mediated signal transduction claimed by Boehringer Ingelheim

Oct. 15, 2004

New analgesic agents identified by Italian researchers

Oct. 15, 2004

Roche presents new anti-HIV reverse transcriptase inhibitors

Oct. 15, 2004

Novel PEPCK inhibitors prepared and tested at Roche

Oct. 15, 2004

New xanthine-based adenosine A1 antagonists covered by Endacea patent

Oct. 15, 2004

Two series of glucokinase activators reported by OSI scientists

Oct. 15, 2004

Three novel series of pyridine-based immunosuppressants developed at AstraZeneca

Oct. 14, 2004

Aventis scientists design inhibitors of fungal CIV1 and other kinases

Oct. 14, 2004

New MIF inhibitors prepared and tested at Avanir

Oct. 14, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...